Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Open accessThe DOI matches its Crossref record; 1,028 of the 1,028 references it cites were found in a registry or an index.
Abstract
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary field that is garnering a lot of interest and investigation. Nanomedicine shows great potential for cancer diagnosis and treatment. Specifically engineered nanoparticles can be employed as contrast agents in cancer diagnostics to enable high sensitivity and high-resolution tumor detection by imaging examinations. Novel approaches for tumor labeling and detection are also made possible by the use of nanoprobes and nanobiosensors. The achievement of targeted medication delivery in cancer therapy can be accomplished through the rational design and manufacture of nanodrug carriers. Nanoparticles have the capability to effectively transport medications or gene fragments to tumor tissues via passive or active targeting processes, thus enhancing treatment outcomes while minimizing harm to healthy tissues. Simultaneously, nanoparticles can be employed in the context of radiation sensitization and photothermal therapy to enhance the therapeutic efficacy of malignant tumors. This review presents a literature overview and summary of how nanotechnology is used in the diagnosis and treatment of malignant tumors. According to oncological diseases originating from different systems of the body and combining the pathophysiological features of cancers at different sites, we review the most recent developments in nanotechnology applications. Finally, we briefly discuss the prospects and challenges of nanotechnology in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 401–600 of 1,028
Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors
Zhang, L., Liu, Y., Huang, H., Xie, H., Zhang, B., Xia, W., & Guo, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114536 · Cited by 176
Wells, J. C., Sharma, S., Del Paggio, J. C., Hopman, W. M., Gyawali, B., Mukherji, D., Hammad, N., Pramesh, C. S., Aggarwal, A., Sullivan, R., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7478 · Cited by 175
Ma, M., Huang, Y., Chen, H., Jia, X., Wang, S., Wang, Z., & Shi, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.001 · Cited by 174
Kamran, N., Kadiyala, P., Saxena, M., Candolfi, M., Li, Y., Moreno-Ayala, M. A., Raja, N., Shah, D., Lowenstein, P. R., & Castro, M. G. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.003 · Cited by 174
Nontoxic, double-deletion-mutant rabies viral vectors for retrograde targeting of projection neurons
Chatterjee, S., Sullivan, H. A., MacLennan, B. J., Xu, R., Hou, Y., Lavin, T. K., Lea, N. E., Michalski, J. E., Babcock, K. R., Dietrich, S., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0091-7 · Cited by 174
Huo, D., Liu, S., Zhang, C., He, J., Zhou, Z., Zhang, H., & Hu, Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b04737 · Cited by 172
Nanotechnology in the diagnosis and treatment of lung cancer
Cryer, A. M., & Thorley, A. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.010 · Cited by 172
New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment
Mottaghitalab, F., Farokhi, M., Fatahi, Y., Atyabi, F., & Dinarvand, R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.009 · Cited by 171
Li, Z., Wang, Y., Shen, Y., Qian, C., Oupicky, D., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.aaz9240 · Cited by 171
Hazrati, A., Soudi, S., Malekpour, K., Mahmoudi, M., Rahimi, A., Hashemi, S. M., & Varma, R. S. (2022) · Biomarker Research · doi:10.1186/s40364-022-00374-4 · Cited by 171
The Microenvironment of Lung Cancer and Therapeutic Implications
Mittal, V., Rayes, T. E., Narula, N., McGraw, T. E., Altorki, N. K., & Barcellos‐Hoff, M. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_5 · Cited by 170
Zuo, H., Tao, J., Shi, H., He, J., Zhou, Z., & Zhang, C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.017 · Cited by 170
A novel electrochemical immunosensor for ultrasensitive detection of CA125 in ovarian cancer
Samadi Pakchin, P., Fathi, M., Ghanbari, H., Saber, R., & Omidi, Y. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112029 · Cited by 170
Design and Synthesis of SERS Materials for In Vivo Molecular Imaging and Biosensing
Li, Q., Huo, H., Wu, Y., Chen, L., Su, L., Zhang, X., Song, J., & Yang, H. (2023) · Advanced Science · doi:10.1002/advs.202202051 · Cited by 170
Yue, C., Yang, Y., Zhang, C., Alfranca, G., Cheng, S., Ma, L., Liu, Y., Zhi, X., Ni, J., Jiang, W., et al. (2016) · Theranostics · doi:10.7150/thno.15433 · Cited by 169
Gong, N., Teng, X., Li, J., & Liang, X.-J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18288 · Cited by 169
Wang, D., Cabalag, C. S., Clemons, N. J., & DuBois, R. N. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.059 · Cited by 169
Janus “nano-bullets” for magnetic targeting liver cancer chemotherapy
Shao, D., Li, J., Zheng, X., Pan, Y., Wang, Z., Zhang, M., Chen, Q.-X., Dong, W.-F., & Chen, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.030 · Cited by 168
Shi, H., Sun, Y., Yan, R., Liu, S., Zhu, L., Liu, S., Feng, Y., Wang, P., He, J., Zhou, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04179 · Cited by 166
Landscape of Noncoding RNA in Prostate Cancer
Hua, J. T., Chen, S., & He, H. H. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.08.004 · Cited by 166
Urease-Powered Polydopamine Nanomotors for Intravesical Therapy of Bladder Diseases
Choi, H., Cho, S. H., & Hahn, S. K. (2020) · ACS Nano · doi:10.1021/acsnano.9b09726 · Cited by 166
Mitigating acute chemotherapy-associated adverse events in patients with cancer
Kuderer, N. M., Desai, A., Lustberg, M. B., & Lyman, G. H. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00685-3 · Cited by 166
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Sun, H., Li, Y., Zhang, P., Xing, H., Zhao, S. Q., Song, Y., Wan, D., & Yu, J. (2022) · Biomarker Research · doi:10.1186/s40364-022-00436-7 · Cited by 166
Lang, J., Zhao, X., Qi, Y., Zhang, Y., Han, X., Ding, Y., Guan, J., Ji, T., Zhao, Y., & Nie, G. (2019) · ACS Nano · doi:10.1021/acsnano.9b04857 · Cited by 165
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis
Lee, Y. J., Shin, K. J., Jang, H.-J., Ryu, J.-S., Lee, C. Y., Yoon, J. H., Seo, J. K., Park, S., Lee, S., Je, A. R., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.01.006 · Cited by 165
Advances in cutaneous squamous cell carcinoma
Winge, M. C. G., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., Sarin, K. Y., Chang, A. L. S., & Khavari, P. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00583-5 · Cited by 165
Li, G., Liu, D., Kimchi, E. T., Kaifi, J. T., Qi, X., Manjunath, Y., Liu, X., Deering, T. G., Avella, D. M., Fox, T. E., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.10.050 · Cited by 164
Tham, H. P., Xu, K., Lim, W. Q., Chen, H., Zheng, M., Thng, T. G. S., Venkatraman, S. S., Xu, C., & Zhao, Y. (2018) · ACS Nano · doi:10.1021/acsnano.8b03007 · Cited by 163
Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment
Clancy, J. W., & D'Souza-Schorey, C. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-022116 · Cited by 162
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
Wang, Q., Liang, Q., Dou, J., Zhou, H., Zeng, C., Pan, H., Shen, Y., Li, Q., Liu, Y., Leong, D. T., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01498-w · Cited by 162
Soni, N., Soni, N., Pandey, H., Maheshwari, R., Kesharwani, P., & Tekade, R. K. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.07.020 · Cited by 161
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
Woodman, C., Vundu, G., George, A., & Wilson, C. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.009 · Cited by 161
Graván, P., Aguilera-Garrido, A., Marchal, J. A., Navarro-Marchal, S. A., & Galisteo-González, F. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102871 · Cited by 161
Chiang, Y., Yen, Y.-W., & Lo, C.-L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.007 · Cited by 160
Polymeric Nanoparticle-Based Activatable Near-Infrared Nanosensor for Protease Determination In Vivo
Lee, S., Ryu, J. H., Park, K., Lee, A., Lee, S. Y., 윤인찬, Ahn, C.-H., Yoon, S. M., Myung, S., Moon, D. H., et al. (2009) · Nano Letters · doi:10.1021/nl902709m · Cited by 160
Nanomedicines for the treatment of hematological malignancies
Deshantri, A. K., Varela-Moreira, A., Ecker, V., Mandhane, S. N., Schiffelers, R. M., Buchner, M., & Fens, M. H. A. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.034 · Cited by 160
Wang, L., Xu, J., Yan, Y., Liu, H., Karunakaran, T., & Li, F. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1594862 · Cited by 160
Self-citationCombining epigenetic and immune therapy to overcome cancer resistance
Gomez, S., Tabernacki, T., Kobyra, J., Roberts, P., & Chiappinelli, K. B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.019 · Cited by 160
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Schmults, C. D., Blitzblau, R. C., Aasi, S. Z., Alam, M., Andersen, J., Baumann, B. C., Bordeaux, J. S., Chen, P.-L., Chin, R., Contreras, C. M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0059 · Cited by 160
Self-citationMyeloid cell heterogeneity in cancer: not a single cell alike
Kiss, M., Van Gassen, S., Movahedi, K., Saeys, Y., & Laoui, D. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.008 · Cited by 159
Clarke, L. E., Warf, M. B., Flake, D. D., Hartman, A., Tahan, S. R., Shea, C. R., Gerami, P., Messina, J. L., Florell, S. R., WENSTRUP, R. J., et al. (2015) · Journal of Cutaneous Pathology · doi:10.1111/cup.12475 · Cited by 159
Guo, S., Vieweger, M., Zhang, K., Yin, H., Wang, H., Li, X., Li, S., Hu, S., Sparreboom, A., Evers, B. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14780-5 · Cited by 159
Self-citationZhang, J., Shen, L., Li, X., Song, W., Liu, Y., & Huang, L. (2019) · ACS Nano · doi:10.1021/acsnano.9b02875 · Cited by 159
Wan, X., Min, Y., Bludau, H., Keith, A., Sheiko, S. S., Jordan, R., Wang, A. Z., Sokolsky-Papkov, M., & Kabanov, A. V. (2018) · ACS Nano · doi:10.1021/acsnano.7b07878 · Cited by 158
He, H., Guo, C., Wang, J., Korzun, W. J., Wang, X.-Y., Ghosh, S., & Yang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01892 · Cited by 158
Dissecting and rebuilding the glioblastoma microenvironment with engineered materials
Wolf, K. J., Chen, J., Coombes, J. D., Aghi, M. K., & Kumar, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0135-y · Cited by 158
Self-citationGuo, J., Yu, Z., Sun, D., Zou, Y., Liu, Y., & Huang, L. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01297-0 · Cited by 158
Li, S., Zhang, T., Xu, W., Ding, J., Yin, F., Xu, J., Sun, W. Y., Wang, H., Sun, M., Cai, Z., et al. (2018) · Theranostics · doi:10.7150/thno.18299 · Cited by 157
Self-citationSupramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
Wang, F., Xu, D., Su, H., Zhang, W., Sun, X., Monroe, M. K., Chakroun, R. W., Wang, Z., Dai, W., Oh, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz8985 · Cited by 157
Self-citationDelivery of cancer therapies by synthetic and bio-inspired nanovectors
Briolay, T., Petithomme, T., Fouet, M., Nguyen-Pham, N., Blanquart, C., & Boisgerault, N. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01346-2 · Cited by 156
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
Xu, J., Liu, Y., Li, Y., Wang, H., Stewart, S., der Jeught, K. V., Agarwal, P., Zhang, Y., Liu, S., Zhao, G., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0381-6 · Cited by 155
Self-citationChallenges and pitfalls in the development of liposomal delivery systems for cancer therapy
Moosavian, S. A., Bianconi, V., Pirro, M., & Sahebkar, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.025 · Cited by 155
Li, S., Zhang, Y., Ho, S., Li, B., Wang, M., Deng, X., Yang, N., Liu, G., Lu, Z., Xu, J., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0573-2 · Cited by 155
Self-citationThe development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy
Tao, H., Wang, R. L., Sheng, W., & Zhen, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.080 · Cited by 155
Liu, J., He, S., Luo, Y., Zhang, Y., Du, X., Xu, C., Pu, K., & Wang, J. (2022) · Advanced Materials · doi:10.1002/adma.202106654 · Cited by 155
Liu, Y., Chen, Z., Liu, C., Yu, D., Lu, Z., & Zhang, N. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.077 · Cited by 154
Polymeric micelles in mucosal drug delivery: challenges towards clinical translation
Sosnik, A., & Menaker Raskin, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.003 · Cited by 154
Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
Wu, W., Pu, Y., & Shi, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01181-z · Cited by 154
The in vivo fate of polymeric micelles
Cai, Y., Qi, J., Lu, Y., He, H., & Wu, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114463 · Cited by 154
Wang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153
Qin, S., Finn, R. S., Kudo, M., Meyer, T., Vogel, A., Ducreux, M. P., Macarulla, T. M., Tomasello, G., Boisserie, F., Hou, J. W.-S., et al. (2019) · Future Oncology · doi:10.2217/fon-2019-0097 · Cited by 153
T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting
Kuang, Y., An, S., Guo, Y., Huang, S., Shao, K., Liu, Y., Li, J., Ma, H., & Jiang, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.019 · Cited by 152
Woensel, M. V., Mathivet, T., Wauthoz, N., Rosière, R., Garg, A. D., Agostinis, P., Mathieu, V., Robert Kiss, A., Lefranc, F., Boon, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01279-1 · Cited by 152
Polymer therapeutics and the EPR effect
Maeda, H. (2017) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1365878 · Cited by 152
Criner, G. J., Eberhardt, R., Fernández-Bussy, S., Gompelmann, D., Maldonado, F., Patel, N. M., Shah, P. L., Slebos, D., Valipour, A., Wahidi, M. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1292so · Cited by 152
Role of exosomal microRNAs in lung cancer biology and clinical applications
Hu, C., Meiners, S., Lukas, C., Stathopoulos, G. T., & Chen, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12828 · Cited by 152
Self-citationCurcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies
Feltrin, F. D. S., Agner, T., Sayer, C., & Lona, L. M. F. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102582 · Cited by 152
Yu, X., Chen, L., Liu, J., Dai, B., Xu, G., Shen, G., Luo, Q., & Zhang, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-08538-x · Cited by 151
Engineered nanomaterials for synergistic photo-immunotherapy
Guo, R., Wang, S., Zhao, L., Zong, Q., Li, T., Ling, G., & Zhang, P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121425 · Cited by 151
Ewing’s Sarcoma: Standard and Experimental Treatment Options
Subbiah, V., Anderson, P. M., Lazar, A. J., Burdett, E., Raymond, K. A., & Ludwig, J. A. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0104-6 · Cited by 150
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Abu‐Rustum, N. R., Yashar, C. M., Bean, S., Bradley, K. A., Campos, S. M., Chon, H. S., Chu, C., Cohn, D. E., Crispens, M. A., Damast, S., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0053 · Cited by 150
Zhao, Z., Ukidve, A., Gao, Y., Kim, J., & Mitragotri, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9250 · Cited by 149
Liu, Q., Wang, C., Zheng, Y., Zhao, Y., Wang, Y., Hao, J., Zhao, X., Yi, K., Shi, L., Kang, C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120275 · Cited by 148
Sasso, M. S., Lollo, G., Pitorre, M., Solito, S., Pinton, L., Valpione, S., Bastiat, G., Mandruzzato, S., Bronte, V., Marigo, I., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.010 · Cited by 147
Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles
Li, X., & Jiang, X. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.015 · Cited by 147
Zhu, L., Kalimuthu, S., Oh, J. M., Gangadaran, P., Baek, S. H., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.034 · Cited by 147
Nanotechnology approaches in the current therapy of skin cancer
Borgheti-Cardoso, L. N., Viegas, J. S. R., Silvestrini, A. V. P., Caron, A. L., Praça, F. S. G., Kravicz, M., & Bentley, M. V. L. B. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.005 · Cited by 147
Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy
Lei, W., Yang, C., Wu, Y. Y., Ru, G., He, X., Tong, X., & Wang, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01251-w · Cited by 147
Conde, J., Oliva, N., & Artzi, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421229112 · Cited by 146
Feng, L., Tao, D., Dong, Z., Chen, Q., Chao, Y., Liu, Z., & Chen, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.027 · Cited by 146
Kristensen, L. S., Ebbesen, K. K., Sokol, M., Jakobsen, T., Korsgaard, U., Eriksen, A. C., Hansen, T. B., Kjems, J., & Hager, H. (2020) · Nature Communications · doi:10.1038/s41467-020-18355-2 · Cited by 146
Recent advances in drug delivery and targeting to the brain
Sethi, B., Kumar, V., Mahato, K., Coulter, D. W., & Mahato, R. I. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.051 · Cited by 144
Engineering strategies to mimic the glioblastoma microenvironment
Rape, A. D., Ananthanarayanan, B., & Kumar, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.012 · Cited by 143
Zhang, L., Zhang, M., Zhou, L., Han, Q., Chen, X., Li, S., Li, L., Su, Z., & Wang, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.060 · Cited by 143
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Khasraw, M., Reardon, D. A., Weller, M., & Sampson, J. H. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1135 · Cited by 143
Kansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 143
Chen, B., Dai, W., Mei, D., Liu, T., Li, S., He, B., He, B., Yuan, L., Zhang, H., Wang, X., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.014 · Cited by 142
Yu, W., Wang, Y., Zhu, J., Jin, L., Liu, B., Xia, K., Wang, J., Gao, J., Liang, C., & Tao, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.019 · Cited by 142
Considerations for designing preclinical cancer immune nanomedicine studies
Jiang, W., Wang, Y., Wargo, J. A., Lang, F. F., & Kim, B. Y. S. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-00817-9 · Cited by 142
Lipid carriers for mRNA delivery
Zhang, W., Jiang, Y., He, Y., Boucetta, H., Wu, J., Chen, Z., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.026 · Cited by 142
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
Miteva, M., Kirkbride, K. C., Kilchrist, K. V., Werfel, T. A., Li, H., Nelson, C. E., Gupta, M. K., Giorgio, T. D., & Duvall, C. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.036 · Cited by 141
Tumor‐derived exosomal proteins as diagnostic biomarkers in non‐small cell lung cancer
Niu, L., Song, X., Wang, N., Xue, L., Song, X., & Xie, L. (2019) · Cancer Science · doi:10.1111/cas.13862 · Cited by 141
Yuan, Z., Fan, G., Wu, H., Liu, C., Zhan, Y., Qiu, Y., Shou, C., Gao, F., Zhang, J., Yin, P., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.017 · Cited by 141
Ji, T., Li, S., Zhang, Y., Lang, J., Ding, Y., Zhao, X., Zhao, R., Li, Y., Shi, J., Hao, J., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11619 · Cited by 140
Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
Guimarães, P. P. G., Gaglione, S. A., Sewastianik, T., Carrasco, R. D., Langer, R., & Mitchell, M. J. (2018) · ACS Nano · doi:10.1021/acsnano.7b05876 · Cited by 140
Mao, B., Liu, C., Zheng, W., Li, X., Ge, R., Shen, H., Guo, X., Lian, Q., Shen, X., & Li, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.045 · Cited by 140
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Marchetti, C., De Felice, F., Romito, A., Iacobelli, V., Sassu, C. M., Corrado, G., Ricci, C., Scambia, G., & Fagotti, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.011 · Cited by 139
Jin, M., Jin, G., Kang, L., Chen, L., Gao, Z., & Huang, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161426 · Cited by 139
Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas
Pappo, A. S., & Dirksen, U. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7402 · Cited by 138
Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles
Shi, X., Sun, K., & Baker, J. R. (2008) · The Journal of Physical Chemistry C · doi:10.1021/jp801293a · Cited by 137
Transferrin–Copper Nanocluster–Doxorubicin Nanoparticles as Targeted Theranostic Cancer Nanodrug
Goswami, U., Dutta, A., Raza, A., Kandimalla, R., Kalita, S., Ghosh, S. S., & Chattopadhyay, A. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15165 · Cited by 137
Pei, P., Yang, F., Liu, J., Hu, H., Du, X., Hanagata, N., Zhao, S., & Zhu, Y. (2018) · Biomaterials Science · doi:10.1039/c8bm00005k · Cited by 137
Li, S., Saw, P. E., Lin, C., Nie, Y., Tao, W., Farokhzad, O. C., Zhang, L., & Xu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119760 · Cited by 136
Chen, Y., Huang, Y., Li, Q., Luo, Z., Zhang, Z., Huang, H., Sun, J., Zhang, L., Sun, R., Bain, D. J., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01266-2 · Cited by 136
Supramolecular Photoactivatable Anticancer Hydrogels
Venkatesh, V., Mishra, N. K., Romero‐Canelón, I., Vernooij, R. R., Shi, H., Coverdale, J. P. C., Habtemariam, A., Verma, S. K., & Sadler, P. J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b00186 · Cited by 134
Recent advances of aptasensors for exosomes detection
Zhu, C., Li, L., Wang, Z., Irfan, M., & Qu, F. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112213 · Cited by 134
Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
Ganguly, D., Chandra, R., Karalis, J. D., Teke, M. E., Aguilera, T. A., Maddipati, R., Wachsmann, M., Ghersi, D., Siravegna, G., Zeh, H. J., et al. (2020) · Cancers · doi:10.3390/cancers12092652 · Cited by 134
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yamada, Y., Satrialdi, S., Hibino, M., Sasaki, D., Abe, J., & Harashima, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.010 · Cited by 134
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Weiss, T., Puca, E., Silginer, M., Hemmerle, T., Pazahr, S., Bink, A., Weller, M., Neri, D., & Roth, P. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb2311 · Cited by 133
Toxicity of inorganic nanomaterials in biomedical imaging
Li, J., Chang, X., Chen, X., Gu, Z., Zhao, F., Chai, Z., & Zhao, Y. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.12.009 · Cited by 133
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Kim, S. S., Harford, J. B., Moghe, M., Rait, A. S., Pirollo, K. F., & Chang, E. H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1221 · Cited by 133
Zhang, X., Xu, X., Li, Y., Hu, C., Zhang, Z., & Gu, Z. (2018) · Advanced Materials · doi:10.1002/adma.201707240 · Cited by 133
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Shakeri, S., Ashrafizadeh, M., Zarrabi, A., Roghanian, R., Afshar, E. G., Pardakhty, A., Mohammadinejad, R., Kumar, A., & Thakur, V. K. (2020) · Biomedicines · doi:10.3390/biomedicines8010013 · Cited by 133
Belov, L., Matic, K. J., Hallal, S., Best, O. G., Mulligan, S. P., & Christopherson, R. I. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.25355 · Cited by 132
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape
Olaussen, K. A., & Postel-Vinay, S. C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw321 · Cited by 132
Garbuzenko, O. B., Kuzmov, A., Taratula, O., Pine, S. R., & Minko, T. (2019) · Theranostics · doi:10.7150/thno.39816 · Cited by 132
Overcoming Chemotherapy Resistance in SCLC
Herzog, B. H., Devarakonda, S. H. K., & Govindan, R. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.018 · Cited by 132
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
Kobiyama, K., Aoshi, T., Narita, H., Kuroda, E., Hayashi, M., Tetsutani, K., Koyama, S., Mochizuki, S., Sakurai, K., Katakai, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319268111 · Cited by 131
Zhang, Q., Kuang, G., He, S., Lu, H., Cheng, Y., Zhou, D., & Huang, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04981 · Cited by 131
Self-citationThe role and application of small extracellular vesicles in gastric cancer
Wu, H., Fu, M., Liu, J., Chong, W., Fang, Z., Du, F., Liu, Y., Shang, L., & Li, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01365-z · Cited by 131
Liu, X., Jiang, J., Chan, R., Ji, Y. C., Lu, J., Liao, Y., Okene, M. O., Lin, J., Lin, P. K., Chang, C. H., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06164 · Cited by 130
Kopeček, J., & Yang, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.020 · Cited by 130
McHugh, M. D., Park, J. Y., Uhrich, R., Gao, W., Horwitz, D. A., & Fahmy, T. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.003 · Cited by 129
Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation
Chen, W., Cheng, C., & Zink, J. I. (2019) · ACS Nano · doi:10.1021/acsnano.8b06655 · Cited by 129
D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy
Du, C., Zhou, M., Jia, F., Ruan, L., Lu, H., Zhang, J., Zhu, B., Liu, X., Chen, J., Chai, Z., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120642 · Cited by 129
Self-citationChen, L., Zhou, X., Nie, W., Zhang, Q., Wang, W., Zhang, Y., & He, C. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11802 · Cited by 127
Xu, C., Wang, Y., Guo, Z., Chen, J., Lın, L., Wu, J., Tian, H., & Chen, X. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.013 · Cited by 127
Self-citationSun, Y., Chen, Y., Ma, X., Yuan, Y., Liu, C., Kohn, J., & Qian, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06094 · Cited by 126
Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
Taghikhani, A., Farzaneh, F., Sharifzad, F., Mardpour, S., Ebrahimi, M., & Hassan, Z. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00221 · Cited by 125
Pirisinu, M., Pham, T. C., Zhang, D. X., Hong, T. N., Nguyen, L. T., & Le, M. T. N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.007 · Cited by 125
Qiu, Y., Wu, Z., Chen, Y., Liao, J., Zhang, Q., Wang, Q., Duan, Y., Gong, K., Chen, S., Wang, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202300878 · Cited by 125
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
Dorrance, A. M., Neviani, P., Ferenchak, G. J., Huang, X., Nicolet, D., Maharry, K. S., Özer, H. G., Hoellarbauer, P., Khalife, J., Hill, E. B., et al. (2015) · Leukemia · doi:10.1038/leu.2015.139 · Cited by 124
Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer
Haugen, B. R., & Sherman, S. I. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1038 · Cited by 124
Nascimento, A. V., Singh, A., Bousbaa, H., Ferreira, D., Sarmento, B., & Amiji, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.045 · Cited by 124
Fang, Z., Li, X., Xu, Z., Du, F., Wang, W., Shi, R., & Gao, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s213974 · Cited by 124
Su, Z., Xiao, Z., Wang, Y., Huang, J., An, Y., Wang, X., & Shuai, X. (2020) · Small · doi:10.1002/smll.201906832 · Cited by 124
Microneedles for gene and drug delivery in skin cancer therapy
Zhi, D., Yang, T., Zhang, T., Yang, M. J., Zhang, S., & Donnelly, R. F. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.009 · Cited by 124
Advanced nanomedicine approaches applied for treatment of skin carcinoma
Kaur, H., & Kesharwani, P. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.003 · Cited by 124
Prospects of nanoparticle-based radioenhancement for radiotherapy
Gerken, L. R. H., Gerdes, M. E., Pruschy, M. N., & Herrmann, I. K. (2023) · Materials Horizons · doi:10.1039/d3mh00265a · Cited by 124
Nanomedicine in treatment of breast cancer – A challenge to conventional therapy
Afzal, M., Ameeduzzafar, Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., Kazmi, I., Kumar, V., Kamal, M. A., Nadeem, M. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.016 · Cited by 123
Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs
Wu, H., Lin, J., Liu, P., Huang, Z., Zhao, P., Jin, H., Ma, J., Wen, L., & Gu, N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.031 · Cited by 122
Lu, Y., Li, L., Lin, Z., Li, M., Hu, X., Zhang, Y., Peng, M., Xia, H., & Han, G. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800602 · Cited by 122
Liao, W., Ho, Y. C., Lin, Y.-W., Raj, E. N., Liu, K., Chen, C., Zhou, X.-Z., Lu, K.-P., & Chao, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.01.025 · Cited by 122
Kozielski, K., Ruiz‐Valls, A., Tzeng, S. Y., Guerrero‐Cazares, H., Rui, Y., Li, Y., Vaughan, H. J., Gionet‐Gonzales, M., Vantucci, C. E., Kim, J., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.020 · Cited by 122
An Overview on Gold Nanorods as Versatile Nanoparticles in Cancer Therapy
Nejabat, M., Samie, A., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.009 · Cited by 122
Challenges in glioblastoma research: focus on the tumor microenvironment
Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J., Bauchet, L., Brisson, L., Cartron, P., Castel, H., Chevet, É., Chneiweiss, H., et al. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.02.006 · Cited by 122
Hsu, C.-C., Chou, P.-T., & Zare, R. N. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03389 · Cited by 121
An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
Bu, J., Nair, A., Iida, M., Jeong, W., Poellmann, M. J., Mudd, K., Kubiatowicz, L. J., Liu, E. W., Wheeler, D. L., & Hong, S. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00953 · Cited by 121
Combinatorial immunotherapy and nanoparticle mediated hyperthermia
Moy, A. J., & Tunnell, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.008 · Cited by 120
Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles
Choi, K. Y., Correa, S., Min, J., Li, J., Roy, S., Laccetti, K. H., Dreaden, E., Kong, S., Heo, R., Roh, Y. H., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900018 · Cited by 120
Polymersome-based protein drug delivery – quo vadis?
Gouveia, M. G., Wesseler, J. P., Ramaekers, J., Weder, C., Scholten, P. B. V., & Bruns, N. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00106c · Cited by 120
Zhang, Z., Ma, R., & Shi, L. (2014) · Accounts of Chemical Research · doi:10.1021/ar5000264 · Cited by 119
Mottaghitalab, F., Kiani, M., Farokhi, M., Kundu, S. C., Reis, R. L., Gholami, M., Bardania, H., Dinarvand, R., Geramifar, P., Beiki, D., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10408 · Cited by 119
Liu, W., Ruan, M., Wang, Y., Song, R., Ji, X., Xu, J., Dai, J., & Xue, W. (2018) · Small · doi:10.1002/smll.201801754 · Cited by 118
Self-citationTao, Y., Tang, Y., Yang, Z., Wu, F., Wang, L., Yang, L., Li, L., Jing, Y., Jiang, X., Jin, H., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39123 · Cited by 118
Zhang, J., Hu, J., Chan, H. F., Skibba, M. E., Liang, G., & Chen, M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.01.017 · Cited by 117
He, X., Chen, X., Liu, L., Zhang, Y., Lü, Y., Zhang, Y., Chen, Q., Ruan, C., Guo, Q., Li, C., et al. (2018) · Advanced Science · doi:10.1002/advs.201701070 · Cited by 117
Xiao, W., Liu, L., Li, X., Wang, Y., Guo, X., Zhao, J., & Zhou, S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.021 · Cited by 117
Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment
Liu, W., Lin, Q., Fu, Y., Huang, S., Guo, C., Li, L., Wang, L., Zhang, Z., & Zhang, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.010 · Cited by 116
Gille, A., Easton, R., D’Andrea, D., Wright, S. D., & Shear, C. L. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303720 · Cited by 115
Luo, L., Iqbal, M. Z., Chuang, L. I. U., Xing, J., Akakuru, O. U., Fang, Q., Li, Z., Dai, Y., Li, A., Guan, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119464 · Cited by 115
Contessotto, P., Orbanić, D., Costa, M. D., Jin, C., Owens, P., Chantepie, S., Chinello, C., Newell, J., Magni, F., Papy-García, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5380 · Cited by 115
Liu, Y., Zhao, G., Xu, C., Luo, Y., Lu, Z.-D., & Wang, J. (2018) · Biomaterials Science · doi:10.1039/c8bm00263k · Cited by 114
Wang, J., Du, X., Yang, J., Shen, S., Li, H., Luo, Y., Iqbal, S., Xu, C., Ye, X., Cao, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.022 · Cited by 114
Tang, W., Fan, W., Wang, Z., Zhang, W., Zhou, S., Liu, Y., Yáng, Z., Shao, E., Zhang, G., Jacobson, O., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06058 · Cited by 114
Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
Brown, Z. J., Greten, T. F., & Heinrich, B. (2019) · Hepatology · doi:10.1002/hep.30633 · Cited by 114
Li, X., Wang, X., Ito, A., & Tsuji, N. M. (2020) · Nature Communications · doi:10.1038/s41467-020-17637-z · Cited by 114
Small cell lung cancer: a slightly less orphan disease after immunotherapy
Remón, J., Aldea, M. D., Besse, B., Planchard, D., Reck, M., Giaccone, G., & Soria, J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.02.025 · Cited by 113
Design of hybrid nanovehicles for remotely triggered drug release: an overview
Liu, J., Detrembleur, C., Mornet, S., Jérôme, C., & Duguet, É. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00664c · Cited by 112
Oxidation-Accelerated Hydrolysis of the Ortho Ester-Containing Acid-Labile Polymers
Song, C.-C., Ji, R., Du, F.-S., Liang, D.-H., & Li, Z.-C. (2013) · ACS Macro Letters · doi:10.1021/mz4000392 · Cited by 112
Hafnium-doped hydroxyapatite nanoparticles with ionizing radiation for lung cancer treatment
Chen, M., Hanagata, N., Ikoma, T., Huang, J.-Y., Li, K.-Y., Lin, C., & Lin, F. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.004 · Cited by 112
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
Palomba, R., Parodi, A., Evangelopoulos, M., Acciardo, S., Corbo, C., de Rosa, E., Yazdi, I. K., Scaria, S., Molinaro, R., Furman, N. E. T., et al. (2016) · Scientific Reports · doi:10.1038/srep34422 · Cited by 112
Gao, D., & Lo, P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.030 · Cited by 112
A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
Lee, S., Yang, C., Peng, C., Wei, M., Chen, K.-C., Yao, C.-J., & Shieh, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.068 · Cited by 111
Bioengineered Magnetoferritin Nanoprobes for Single-Dose Nuclear-Magnetic Resonance Tumor Imaging
Zhao, Y., Liang, M., Li, X., Fan, K., Xiao, J., Li, Y., Shi, H., Wang, F., Choi, H. S., Cheng, D., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07408 · Cited by 111
Luo, X., Peng, X., Hou, J., Wu, S., Shen, J., & Wang, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137245 · Cited by 111
Sedláček, O., Monnery, B. D., Mattová, J., Kučka, J., Pánek, J., Janoušková, O., Höcherl, A., Verbraeken, B., Vergaelen, M., Zadinová, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.003 · Cited by 111
Huang, L., Wang, D.-B., Singh, N., Yang, F., Gu, N., & Zhang, X. (2018) · Nanoscale · doi:10.1039/c8nr07720g · Cited by 111
Yang, Y., Kannisto, E. D., Yu, G., Reid, M. E., Patnaik, S. K., & Wu, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b13971 · Cited by 111
Implications of nanotechnology for the treatment of cancer: Recent advances
Klochkov, S. G., Неганова, М. Е., Nikolenko, V. N., Chen, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.028 · Cited by 111
Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications
Sabra, S. A., & Agwa, M. M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.167 · Cited by 111
Dell’Oglio, P., de Vries, H. M., Mazzone, E., KleinJan, G. H., Donswijk, M. L., van der Poel, H. G., Horenblas, S., van Leeuwen, F. W. B., & Brouwer, O. R. (2020) · European Urology · doi:10.1016/j.eururo.2020.09.007 · Cited by 111
Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics
Llop, J., & Lammers, T. (2021) · ACS Nano · doi:10.1021/acsnano.1c09139 · Cited by 111
Functionalized chitosan for cancer nano drug delivery
Zaiki, Y., Iskandar, A., & Wong, T. W. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108200 · Cited by 111
Label‐Free Optofluidic Nanobiosensor Enables Real‐Time Analysis of Single‐Cell Cytokine Secretion
Li, X., Soler, M., Szydzik, C., Khoshmanesh, K., Schmidt, J., Coukos, G., Mitchell, A., & Altug, H. (2018) · Small · doi:10.1002/smll.201800698 · Cited by 110
Wu, T., Duan, X., Hu, C., Wu, C., Chen, X., Huang, J., Liu, J., & Cui, S. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1560305 · Cited by 110
RNA-based therapies: A cog in the wheel of lung cancer defense
Κhan, P., Siddiqui, J. A., Lakshmanan, I., Ganti, A. K., Salgia, R., Jain, M., Batra, S. K., & Nasser, M. W. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01338-2 · Cited by 110
Toxicity and efficacy of chronomodulated chemotherapy: a systematic review
Printezi, M. I., Kilgallen, A. B., Bond, M. J. G., Štibler, U., Putker, M., Teske, A. J., Cramer, M. J., Punt, C. J. A., Sluijter, J. P. G., Huitema, A. D. R., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00639-2 · Cited by 110
Li, J., Wu, C., Hou, P., Zhang, M., & Xu, K. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.047 · Cited by 109
Zhang, B., Xing, L., Cui, P., Wang, F., Xie, R.-L., Zhang, J., Zhang, M., He, Y., Lyu, J.-Y., Qiao, J.-B., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.027 · Cited by 108
Wu, J., Deng, C., Meng, F., Zhang, J., Sun, H., & Zhong, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.024 · Cited by 108
Lee, J. M., Arao, R. F., Sprague, B. L., Kerlikowske, K. M., Lehman, C. D., Smith, R. A., Henderson, L. M., Rauscher, G. H., & Miglioretti, D. L. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.8372 · Cited by 108
Nanomedicines for Renal Management: From Imaging to Treatment
Jiang, D., Rosenkrans, Z. T., Ni, D., Lin, J., Huang, P., & Cai, W. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00323 · Cited by 108
Recent advances in chitosan-based layer-by-layer biomaterials and their biomedical applications
Hu, B., Guo, Y., Li, H., Liu, X., Fu, Y., & Ding, F. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118427 · Cited by 108
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
Liu, Y., Wang, J., Hu, X., Pan, Z., Xu, T., Xu, J., Jiang, L., Huang, P. C., Zhang, Y., & Ge, M. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100939 · Cited by 108
Self-citationEfficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma
Toub, N., Bertrand, J., Tamaddon, A. M., Elhamess, H., Hillaireau, H., Maksimenko, A., Maccario, J., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9901-9 · Cited by 106
Ng, S., Tan, W. J., Pek, M. M. X., Tan, M.-H., & Kurisawa, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119400 · Cited by 105
The Combination of Chemotherapy and Radiotherapy towards More Efficient Drug Delivery
Cao, W., Gu, Y., Meineck, M., & Xu, H. (2013) · Chemistry - An Asian Journal · doi:10.1002/asia.201301294 · Cited by 105
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
Yi, Y., Hsieh, I.-Y., Huang, X., Li, J., & Zhao, W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00477 · Cited by 105
Jiang, B., Zhang, L., Guo, X., Shen, X., Wang, Y., Zhu, Y., & Liang, H. (2016) · Small · doi:10.1002/smll.201602496 · Cited by 105
Cited by
Exploring and bypassing resistance to targeted therapies in colorectal cancer
Favier, S., Xiong, W., Chalabi-Dchar, M., Chettab, K., Piercey, O., Wu, T., Fenouil, T., Albaret, M.-A., Jordheim, L. P., Diaz, J.-J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118741 · Cited by 12
Tao, J., Ning, W., Lu, W., Wang, R., Zhou, H., Zhang, H., Xu, J., Wang, S., Teng, Z., & Wang, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.058 · Cited by 10
Self-citation
Metadata
- Authors
- Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-08-12
- Volume
- 9
- Issue
- 1
- Pages
- 200-200
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4401497204
- Cited by
- 558
- References
- 1,028
- FWCI
- 58.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.